Synopsis: Gold and silver prices witnessed a sharp “Double-Digit” meltdown on February 17, 2026, with MCX Gold dropping over ₹1,300 to settle near ₹1,56,590 per 10g. The “Zero-Minute” fact is that a strengthening US Dollar Index (DXY) at 97.14 and aggressive profit booking after a 20% January rally triggered a massive sell-off. Silver faced even […]
Synopsis: Krishna Defence and Allied Industries Ltd (NSE: KRISHNADEF) reported an explosive Q3 FY26 performance on February 14-16, 2026, with consolidated net profit surging 164.42% YoY to ₹10.18 Crore. The “Zero-Minute” fact is that revenue climbed 31.64% QoQ to ₹63.66 Crore, fueled by high-margin naval bulb bar orders and the company’s strategic shift towards indigenization
Synopsis: RHI Magnesita India Ltd (NSE: RHIM) shares skyrocketed 8% to an intraday high of ₹471.50 on February 16, 2026, following a blockbuster Q3 FY26 earnings report. The “Zero-Minute” fact is that consolidated net profit jumped 61% sequentially to ₹61.6 Crore, supported by record quarterly revenue of ₹1,092 Crore. Investors are aggressively re-rating the stock
Synopsis: The Nifty 50 (NSE: NIFTY) staged a remarkable 250-point recovery from its intraday low of 25,372 on February 16, 2026, climbing back above the 25,600 level by mid-day. The “Zero-Minute” fact is that a sharp 1.5% breakout in HDFC Bank and a sustained rally in PSU banks like SBI (up 3.4%) provided the necessary
Synopsis: Fractal Analytics Ltd (NSE: FRACTAL) shares plunged 5.33% from their issue price on February 16, 2026, after a muted debut at a 2.67% discount. The “Zero-Minute” fact is that the stock listed at ₹876 against the ₹900 issue price, eventually hitting an intraday low of ₹852. The crash was triggered by a “Zero-to-Negative GMP”
Synopsis: Natco Pharma Ltd (NSE: NATCOPHARM) shares surged over 11% to reach ₹918 on February 16, 2026, following the CDSCO approval to manufacture and market generic Semaglutide injection in India. The breakout was fueled by a massive 6.4x spike in trading volume and positive Q3 FY26 results showing a 14.3% YoY profit jump to ₹151.3
Synopsis: Fractal Analytics (NSE: FRACTAL) made a disappointing stock market debut on February 16, 2026, listing at ₹876—a 2.67% discount to its ₹900 issue price. Simultaneously, MSME-lender Aye Finance (NSE: AYEF) saw a flat listing at ₹129. The muted performance was triggered by a “Zero GMP” signal in the grey market and a massive ₹1.3
Synopsis: Heavyweights HDFC Bank (NSE: HDFCBANK) and Reliance Industries (NSE: RELIANCE) spearheaded a brutal market sell-off on February 13-15, 2026, as investors grappled with a ₹7.02 Lakh Crore wipeout in total market capitalization. The panic was triggered by a massive ₹7,395 Crore FPI exit, the “Anthropic Shock” disrupting the tech sector, and stronger-than-expected US jobs
On February 14, 2026, the Indian mutual fund industry is witnessing a shift led by the full-scale implementation of SEBI’s MF Lite Framework. With a regulatory “light-touch” approach designed specifically for passively managed schemes, the strategy offers a masterclass in reducing financial friction for the retail investor. The Market Gap: The “Active-Style” Regulatory Burden on
Synopsis: Kwality Wall’s (India) Ltd (KWIL) is set to debut on the NSE and BSE on February 16, 2026, marking the completion of Hindustan Unilever’s (HUL) landmark ice cream demerger. Under the 1:1 share entitlement ratio, HUL shareholders as of the December 5 record date have been allotted one free share of KWIL for every
Synopsis: Biocon Limited (NSE: BIOCON) reported a staggering 475% YoY surge in consolidated net profit to ₹144 Crore for Q3 FY26, supported by a 9% rise in operating revenue to ₹4,173 Crore. The sharp turnaround was driven by robust momentum in the Generics segment and the full integration of Biocon Biologics as a wholly-owned subsidiary.
